Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Well done BigBiteNow. Great notes and synopsis of yesterday’s presentation.
I sold out early yesterday, then listened to the presentation and immediately bought back on the basis of the reduced P3 trial costs and re-engagement with pharma companies and the statements regarding efficacy against MRSA and minimal risk of liver/kidney toxicity.
He already owns the 99 million shares.
He’s buying a few now in the market and no doubt the lemmings will follow and he can punt them out at a higher price.
Why sell now ahead of TO13 flow test?
Why would he take it now?
Better to wait for the results of the flow test results.
If they are good, price goes up and he retains his shares.
If bad, he cashes out at 0.75p.
You don’t understand what a put option is?
He can cash out £750k at anytime up to September 1st regardless of where the share price goes.
He’s quids in!
Well they have approximately one years cash flow in the bank, so the CEO had better start signing some commercial agreements pretty soon to fund the technology roadmap.
The share price has already fallen 40% from the last placing, so I doubt there will be much appetite from the market to provide further funding, let alone us poor sods who are 90% down from the IPO!
If Amati want out, why has the CEO not contacted Bracco or Nukem to purchase their holding.
Nukem increased their stake in August by 0.5% when the share price was 15p, whilst Branco invested in the last capital raise at I think 60p. For little more than £1m they could acquire a 10% stake in the company. It makes no sense to allow a continual drip feed of sales to trash the share price, unless of course they have lost complete faith in the prospects for the company.
seems strange that for a supposed revolution in lung imaging technology, the company seems completely incapable of commercialising the product.
what we don’t need is the ceo/cfo trotting through a 25 page interim results presentation leaving minimal time for questions. we all know what the company does. we require an honest assessment from the new ceo of the company’s commercial development, and more importantly how they intend to finance the company going forward. the time for bull****ting is over.